COH – Algo Buy Signal

Posted on | by Leon Hinde

Cochlear is now under Algo Engine buy conditions and has been added to our ASX 100 model portfolio.

We expect 10% EPS growth over the next 12 months. Although, the stock remains expensive at 40x earnings and trading on a 1.8% yield.

Since writing the above post in Dec last year, COH has rallied from $175 to a high of $257. The subsequent pullback has seen buying interest rebuild at the higher low of $210.

This is the second cluster of Algo Engine buy signals and we’ve taken the opportunity to add to our original allocation.

Wesfarmers – Buy

Posted on | by Leon Hinde

Wesfarmers is under Algo Engine buy conditions and is a current holding in our model portfolio.

Wesfarmers now holds 19.3% of Australian Pharmaceutical Industries. The acquisition has less than two weeks left in confirmatory due diligence. The battle between Sigma and Wesfarmers for the API business and final offers will be worth watching.

Accumulate WES within the $50 – $56 price range.

.

CIMIC – Buy

Posted on | by Leon Hinde

CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.

CIMIC is a high-risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.

.

iShares Asia 50 ETF – Buy

Posted on | by Leon Hinde

iShares Asia 50 is under Algo Engine buy conditions and is a current holding in our iShares ETF model.

INVESTMENT OBJECTIVE: The fund aims to provide investors with the performance of the S&P Asia 50TM Index, before fees and expenses. The index is designed to measure the performance of the 50 leading companies listed in China, Hong Kong, Macau, Singapore, South Korea and Taiwan.

CIMIC – Buy

Posted on | by Leon Hinde

CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.

CIMIC is a high-risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.

.